• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.

    Avenzo Begins Ph 1/2 Trial of CDK4 Inhibitor AVZO-023

    BUSINESSWIRE

    Avenzo Therapeutics Begins Phase 1/2 Study of AVZO-1418

    BUSINESSWIRE

    Avenzo Therapeutics FDA Clears AVZO-1418 Drug Application

    BUSINESSWIRE

    Avenzo Therapeutics FDA clears AVZO-023, a CDK4 inhibitor

    BUSINESSWIRE

    Avenzo, DualityBio Announce EGFR/HER3 Antibody-Drug License

    BUSINESSWIRE

    Avenzo, Gilead Collaborate on Clinical Study for Metastatic Breast Cancer

    BUSINESSWIRE

    Sands Capital raises new $555M life sci fund

    FIERCE BIOTECH

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.